[Federal Register Volume 80, Number 232 (Thursday, December 3, 2015)]
[Notices]
[Page 75689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30556]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Fresenius Kabi 
USA, LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Fresenius Kabi USA, LLC applied to be registered as an 
importer of a certain basic class of controlled substance. The Drug 
Enforcement Administration (DEA) grants Fresenius Kabi USA, LLC 
registration as an importer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated September 16, 2015, and 
published in the Federal Register on September 23, 2015, 80 FR 57389 
Fresenius Kabi USA, LLC, 3159 Staley Road, Grand Island, New York 14072 
applied to be registered as an importer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Fresenius Kabi USA, LLC 
to import the basic class of controlled substance is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of remifentanil (9739), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
product development and preparation of stability batches.

    Dated: November 27, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-30556 Filed 12-2-15; 8:45 am]
BILLING CODE 4410-09-P